Delivery Order SPE2DB22D3501-SPE2DB24FVL46
- Not listed
- This federal contract award, with the ID SPE2DB20D1100|SPE2DB25FB5J1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567793603 VERZENIO 150 MG TABLET UU 14S, with a firm fixed price of $14,907.28 and a completion date of April 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6CVF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,006.48 firm fixed-price delivery order is for the pharmaceutical product VERZENIO 100 MG TABLET UU 14S. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2023. There was no set-aside designation for this open competition award....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Delivery Order, valued at $13,228.97, is for the provision of the pharmaceutical product VERZENIO 150 MG TABLET. The contract has a Firm Fixed Price pricing type and an ultimate completion date of February 15, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $11,340.60, is for the delivery of VERZENIO 150 MG TABLET and has an ultimate completion date of November 24, 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award, with the ID SPE2DB22D3501|SPE2DB24FVV38, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a ceiling value of $12,430.78. The contract is for the supply of 4564766038 - VERZENIO 100 MG TABLET UU 14S, a pharmaceutical product, with a period of performance through June 3, 2024. The contract does not have a set-aside designation,...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of VERZENIO 150 MG TABLET in quantities of 14s. The contract has a ceiling value of $53,957.76 and a completion date of September 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp for the supply of VERZENIO 150 MG TABLET. The $9,101.24 firm fixed-price delivery order is associated with a larger indefinite delivery contract valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does...
- This federal contract award, valued at $14,006.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VERZENIO 150 MG TABLET UU 14S, a medical product, and has a completion date of June 25, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,015.27, is a delivery order for the supply of VERZENIO 150 MG TABLET UU 14S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through March 6, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VERZENIO 100 MG TABLET pharmaceutical products. The single-award Delivery Order, valued at $7,003.24, has a firm fixed-price pricing type and a period of performance ending on January 9, 2024. The contract does not have a set-aside designation, indicating open competition. As a prime contractor, Amerisourcebergen Drug Corp will be...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVL46Delivery Order
This federal contract award with ID SPE2DB22D3501|SPE2DB24FVL46 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of VERZENIO 150 MG TABLET in units of 14. The contract has a ceiling value of $14,006.48 and is a Firm Fixed Price Delivery Order with a completion date of April 29, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 4/26/24 |